» Articles » PMID: 37707552

Bone Turnover in Lactating and Nonlactating Women

Overview
Date 2023 Sep 14
PMID 37707552
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: During lactation, bone turnover increases, reflecting the mobilization of Calcium from maternal skeletal stores and resulting in bone loss. However, mechanisms are not yet fully understood, and previous studies have been comparatively small. We aim to assess bone metabolism during lactation by comparing bone-metabolism-related-parameters between large cohorts of lactating and nonlactating women.

Methods: In a retrospective cohort study, we recruited 779 postpartum women and 742 healthy, nonpregnant, nonlactating controls. Postpartum women were examined 3 and 6 months after delivery and retrospectively assigned to either the exclusively breastfeeding (exc-bf) group if they had exclusively breastfed or the nonexclusively breastfeeding (nonexc-bf) group if they had not exclusively breastfed up to the respective visit. Serum levels of PTH, Estradiol, total Calcium, Phosphate, and bone turnover markers (ßCTX, P1NP, Osteocalcin) were compared between the groups.

Results: Bone turnover markers were significantly increased in exc-bf and nonexc-bf women compared with the controls (all ps < .001). ßCTX was approximately twice as high in exc-bf women than in the controls. PTH levels were marginally higher in exc-bf (p < .001) and nonexc-bf women (p = .003) compared with the controls (6 months). Estradiol was suppressed in exc-bf women compared with the controls (p < .001, 3 months).

Conclusion: Exc-bf and even nonexc-bf states are characterized by an increase in bone formation and resorption markers. The PTH data distribution of exc-bf, nonexc-bf, and control groups in the underpart of the reference range suggest that lactational bone loss is relatively independent of PTH.

Citing Articles

Current and future perspectives on pregnancy and lactation-associated osteoporosis.

Gak N, Abbara A, Dhillo W, Keen R, Comninos A Front Endocrinol (Lausanne). 2024; 15:1494965.

PMID: 39703866 PMC: 11655223. DOI: 10.3389/fendo.2024.1494965.


Effective strategies for pregnancy and lactation-associated osteoporosis: teriparatide use in focus.

Ali D, Khan A, Brandi M Endocrine. 2024; 86(2):459-469.

PMID: 39008200 DOI: 10.1007/s12020-024-03946-6.

References
1.
Wysolmerski J . Interactions between breast, bone, and brain regulate mineral and skeletal metabolism during lactation. Ann N Y Acad Sci. 2010; 1192:161-9. PMC: 3777748. DOI: 10.1111/j.1749-6632.2009.05249.x. View

2.
Sowers M . Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res. 1996; 11(8):1052-60. DOI: 10.1002/jbmr.5650110803. View

3.
Kalkwarf H, Specker B, Bianchi D, Ranz J, Ho M . The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med. 1997; 337(8):523-8. DOI: 10.1056/NEJM199708213370803. View

4.
Kovacs C, Kronenberg H . Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev. 1997; 18(6):832-72. DOI: 10.1210/edrv.18.6.0319. View

5.
Sowers M, Hollis B, Shapiro B, Randolph J, Janney C, Zhang D . Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA. 1996; 276(7):549-54. View